Circulating immune index predicting the prognosis of patients with hepatocellular carcinoma treated with lenvatinib and immunotherapy

Circulating immune index predicting the prognosis of patients with hepatocellular carcinoma treated with lenvatinib and immunotherapy

BackgroundImmune checkpoint inhibitor (ICI)-based combination therapy has opened a new avenue for the treatment of multiple malignancies including hepatocellular carcinoma (HCC). However, considering the unsatisfactory efficacy, biomarkers are urgently needed to identify the patients most likely to...

Full description

Bibliographic Details
Main Authors: De-Zhen Guo, Shi-Yu Zhang, San-Yuan Dong, Jia-Yan Yan, Yu-Peng Wang, Ya Cao, Sheng-Xiang Rao, Jia Fan, Xin-Rong Yang, Ao Huang, Jian Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
prognostic models
immunotherapy
lenvatinib
circulating immune index
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1109742/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1109742/full

Similar Items